Quanta Dialysis Technologies

Quanta Dialysis Technologies

Based in the Midlands of the United Kingdom, Quanta is a technology-enabled provider of innovative dialysis products and services. Quanta aims to improve the lives of dialysis patients through beautifully engineered solutions. The lead product, SC+, is a small, simple and versatile haemodialysis system designed to provide greater freedom and flexibility in the delivery of life sustaining dialysis treatment – making the therapy manageable to a broad range of users across a wide range of environments, from the ICU to the home.

As a CE marked medical device, SC+ has been successfully piloted with the NHS, demonstrating clinical efficacy and performance compatible with traditional treatment regimens used in-centre. The innovative and patented technology behind SC+ is based on a design breakthrough that allows all dialysate fluid management to be conducted on a small, lightweight, disposable cartridge. The unobtrusive, simple-to-use and digitally connected design of SC+ is intended to empower more patients to take control of their lives with selfcare and home dialysis. Meanwhile, as a portable, compact and versatile device, SC+ supports dialysis delivery across a range of care settings and therapy prescriptions.

For more information, please visit our website: quantadt.com.

SC+ is not yet FDA cleared and not yet available for sale or use in the USA.

News and Links:

Contact Info

Quanta Dialysis Technologies has been a sponsor of Home Dialysis Central since 2015

Spotlight Archive